tiprankstipranks
Pharmaron Beijing Co., Ltd. Class H (DE:17Q1)
FRANKFURT:17Q1
Germany Market
17Q1
Pharmaron Beijing Co., Ltd. Class H
RESEARCH TOOLSreports

Pharmaron Beijing Co., Ltd. Class H (17Q1) Income Statement

0 Followers

Pharmaron Beijing Co., Ltd. Class H Income Statement

Last quarter (Q4 2025), Pharmaron Beijing Co., Ltd. Class H's total revenue was ¥3.95B, an increase of 14.22% from the same quarter last year. In Q4, Pharmaron Beijing Co., Ltd. Class H's net income was ¥522.99M. See Pharmaron Beijing Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 14.10B¥ 12.28B¥ 11.54B¥ 10.27B¥ 7.44B
Gross Profit
¥ 4.91B¥ 4.20B¥ 4.12B¥ 3.77B¥ 2.68B
Operating Expenses
¥ 2.98B¥ 2.10B¥ 2.28B¥ 2.02B¥ 1.15B
Depreciation and Amortization
¥ 1.18B¥ 1.05B¥ 927.17M¥ 696.18M¥ 497.92M
EBITDA
¥ 3.29B¥ 3.38B¥ 2.95B¥ 2.53B¥ 2.49B
Operating Income
¥ 1.93B¥ 2.10B¥ 1.85B¥ 1.69B¥ 1.91B
Other Income/Expenses
¥ -15.76M¥ -13.20M¥ -10.01M¥ -23.50M¥ -3.34M
Pretax Income
¥ 1.91B¥ 2.09B¥ 1.84B¥ 1.67B¥ 1.91B
Net Income
¥ 1.66B¥ 1.79B¥ 1.60B¥ 1.37B¥ 1.66B
Per Share Metrics
Basic EPS
¥ 0.94¥ 1.01¥ 1.00¥ 0.90¥ 1.12
Diluted EPS
¥ 0.94¥ 1.01¥ 1.00¥ 0.90¥ 1.10
Weighted Average Shares Outstanding
 1.76B 1.79B 1.77B 1.77B 1.78B
Weighted Average Shares Outstanding (Diluted)
 1.77B 1.79B 1.78B 1.78B 1.81B
Currency in CNY

Pharmaron Beijing Co., Ltd. Class H Earnings and Revenue History